Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Oct 2024 for Augmedix, Inc., €88k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert C. Faulkner: trading record in brief
Robert C. Faulkner (board member) discloses dealings in 2 companies, chiefly Augmedix, Inc. and Science 37 Holdings, Inc. Between 23 May 2022 and 2 October 2024, the trades on record add up to 9 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 4 October 2024 with a transaction (€88k) in Augmedix, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert C. Faulkner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
41,461 shares@ US$2.3590.5% of flowCommon StockSEC:0001104659-24-106311:0
12,879 shares0Common StockSEC:0001104659-24-073006:0
3,125 shares0Common StockSEC:0001104659-24-036340:0
26,791 shares@ US$5.7537.8% of flowCommon StockSEC:0001104659-24-034013:0
1,767 shares0Common StockSEC:0001104659-23-127454:0
2,092 shares@ US$4.789.5% of flowCommon StockSEC:0001104659-23-098444:0
21,598 shares0Common StockSEC:0001104659-23-081725:0
494,853 shares@ US$0.252630.8% of flowCommon StockSEC:0001104659-23-061087:0
40,983 shares@ US$3.0531.4% of flowCommon StockSEC:0001104659-22-064849:0
9 of 9 declarations
